China is the world’s second largest pharmaceutical market after the US and the large♑st producer and exporter of active pharmaceutical ingredients (APIs) globall♔y. Since it is the world’s most populous country, with a large share of ageing ...

The economy&r♚squo;s return to growth provided a strong impetus to the Russian healthcare sector in 2017. Healthcare expenditure grew ꦇby a robust 22% y/y, when measured in US dollar terms, the first increase in many years. However, at USD 92bn in 2017 ...

With 1.4bn population each as of 2017, India and China are the♔ most numerous countries out of the six forming the focus of this report. However, the two countries differ widely in terms of per capita GDP, with that of Chi♛na being more than twice that ...

Peru is a comparatively small pharmaceutical market in Latin America (ranking eighth in terms of sales volume in 2017), with a relatively young and grow🍸ing population. However, publ💖ic health spending is expanding at a rapid pace, particularly in ...

India’s is the world’s 10th-largest pharmaceutical market in US dollar terms - with sales of over USD 25bn in 2017 - and the largest generic drug manufaওcturer and exporter globally. Strong🌃 domestic demand and robust exports have ...

The gross value added (GVA) of the Czech pharmaceutical sector amounted to CZK 19.4bn in 2017, increasing by🌠 a real 11.1% y/y. The sector ac☂counted for 0.4% of the GDP that year. The pharmaceutical sector employed 9,855 workers in 2017, accounting ...

Although the global pharma & healthcare sector is dominated by large multinational companies, mainly from the developed countries, Latin America has been quickly catching up𝐆 in building a domestic pharmaceutical production base and expanding the ...

In the third quarter of 2018, China&rsq൩uo;s pharmaceutical and medicine production declined by 28.5% y/y to 573,000 tonnes, In 2018, ꦰmany pharmaceutical producers were affected by the ongoing reform for new chemical drugs classification system, and ...

Mexico is the second-largest pharmaceutical markeౠt in Latin America, behind only Brazil, with a large and growing population, multiple but underfunded state-run health i🃏nsurance schemes, and a small but rapidly developing private health insurance ...

Indonesia&ಌrsquo;s pharmaceutical and healthcare sector is under-developed compared to many other countries in the Association of Southeast Asian Nations (ASEAN). Indonesia has one of the fewest physicians and hospital beds per 1,000 population in the ...